Background Recently in China, HCV 6a infection has shown a fast increase among patients and blood donors, possibly due to IDU linked transmission. Methodology/Findings We recruited 210 drug users in Shanwei city, Guangdong province. Among them, HCV RNA was detected in 150 (71.4%), both E1 and NS5B genes were sequenced in 136, and 6a genotyped in 70. Of the 6a sequences, most were grouped into three clusters while 23% represent emerging strains. For coalescent analysis, additional 6a sequences were determined among 21 blood donors from Vietnam, 22 donors from 12 provinces of China, and 36 IDUs from Liuzhou City in Guangxi Province. Phylogeographic analyses indicated that Vietnam could be the origin of 6a in China. The Guangxi Province, which borders Vietnam, could be the first region to accept 6a for circulation. Migration from Yunnan, which also borders Vietnam, might be equally important, but it was only detected among IDUs in limited regions. From Guangxi, 6a could have further spread to Guangdong, Yunnan, Hainan, and Hubei provinces. However, evidence showed that only in Guangdong has 6a become a local epidemic, making Guangdong the second source region to disseminate 6a to the other 12 provinces. With a rate of 2.737×10？3 (95% CI: 1.792×10？3 to 3.745×10？3), a Bayesian Skyline Plot was portrayed. It revealed an exponential 6a growth during 1994–1998, while before and after 1994–1998 slow 6a growths were maintained. Concurrently, 1994–1998 corresponded to a period when contaminated blood transfusion was common, which caused many people being infected with HIV and HCV, until the Chinese government outlawed the use of paid blood donations in 1998. Conclusions/Significance With an origin from Vietnam, 6a has become a local epidemic in Guangdong Province, where an increasing prevalence has subsequently led to 6a spread to many other regions of China.
References
[1]
Bao YP, Liu ZM (2009) Current situation and trends of drug abuse and HIV/AIDS in China. HIV Ther 3: 237–240.
[2]
Peng JS, Wang X, Liu MQ, Zhou DJ, Gong J, et al. (2008) Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China. Virus Res 135: 191–196.
[3]
Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, et al. (2008) Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One 3: e3608.
[4]
Garten RJ, Lai S, Zhang J, Liu W, Chen J, et al. (2004) Rapid transmission of hepatitis C virus among young injection heroin users in Southern China. Int J Epidemiol 33: 182.
[5]
Bao Y, Liu Z, Lu L (2010) Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry 23: 187–194.
[6]
Garten R, Zhang J, Lai S, Liu W, Chen J, et al. (2005) Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 41: S18–24.
[7]
Zhong W (2000) “A close look at China's sex industry” (D. Cowhig, Transl.), Lianhe Zaobao (Singpore), 2 October.
[8]
Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, et al. (2005) Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75: 538–549.
[9]
Fu Y, Wang Y, Xia W, Pybus OG, Qin W, et al. (2011) New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Virol Hepat 18: 42–52.
[10]
Xia X, Lu L, Tee KK, Zhao W, Wu J, et al. (2008) The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol 80: 1142–1152.
[11]
Drummond AJ, Rambaut A, Shapiro B, Pybus OG (2005) Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol 22: 1185–1192.
[12]
Posada D (2009) Selection of models of DNA evolution with jModelTest. Methods Mol Biol 537: 93–112.
[13]
Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
[14]
Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, et al. (2009) Genetic history of hepatitis C virus in East Asia. J Virol 2009 83: 1071–1082.
[15]
Yang Z (1993) Maximum-likelihood estimation of phylogeny from DNA sequences when substitution rates differ over sites. Mol Biol Evol 10: 1396–1401.
[16]
Gu X, Fu YX, Li WH (1995) Maximum likelihood estimation of the heterogeneity of substitution rate among nucleotide sites. Mol Biol Evol 12: 546–557.
[17]
Soltis PS, Soltis DE, Savolainen V, Crane PR, Barraclough TG (2002) Rate heterogeneity among lineages of tracheophytes: integration of molecular and fossil data and evidence for molecular living fossils. Proc Natl Acad Sci USA 99: 4430–4435.
[18]
Wang TH, Donaldson YK, Brettle RP, Bell JE, Simmonds P (2001) Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol 75: 11686–11699.
[19]
Slatkin M, Maddison WP (1989) A cladistic measure of gene flow measured from the phylogenies of alleles. Genetics 123: 603–613.
[20]
Parker J, Rambaut A, Pybus OG (2008) Correlating viral phenotypes with phylogeny: accounting for phylogenetic uncertainty. Infect Genet Evol 8: 239–246.
[21]
Ji Y, Ren QH, Zhu ZY, Qu DM, Qiu ZK, et al. (1998) Investigation and analysis of HCV infection in Chinese blood donors. Acta Acad Med Sinica 203: 240–241.
[22]
Shi XL, Ren QH, Zhu ZY, Qu DM, Ji Y, et al. (1999) Hepatitis C virus infection in blood donors in the People's Republic of China. Transfusion 39: 913.
[23]
Kaufman J, Jing J (2002) China and AIDS-The Time to Act Is Now. Science 296: 2339–2340.
[24]
Deadly Secret: AIDS in China. CBS News August 11, 2006 www.cbc.ca/news/background/aids/aids-chi？na.html.
[25]
Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, et al. (2002) Blood banking in China. Lancet 360: 1770–1775.
[26]
Lee K, Chan D, Lee SS (2008) Molecular epidemiology of HCV genotype in injecting drug users in Hongkong. International J Infect Dis 12: Suppl 1e424–425.
[27]
Liu J, Lin H, Liu Y, Lee SS, Chen YL, et al. (2008) Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin Infect Dis 46: 1761–1768.
[28]
Lee Y, Lin H, Chen Y, Lee CM, Wang SF, et al. (2010) Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. J Med Virol 82: 57–68.
[29]
Zhou X, Chan PK, Tam JS, Tang JW (2011) A possible geographic origin of endemic hepatitis C virus 6a in Hong Kong: evidences for the association with vietnamese immigration. PLoS One 6: e24889.
[30]
Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, et al. (2008) High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 48: 1746–1752.
